Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533061 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients - T Cells
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 24
- Enrollment target
NCT04533061 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants.
The verdict
NCT04533061 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This trial is designed to investigate the hypothesis that there is no difference in T Cell response to the influenza vaccine between lung transplant patients and healthy controls.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04533061
The ClinicalTrials.gov registry entry for NCT04533061 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT04533061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04533061 about?
NCT04533061 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients - T Cells". This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This trial is designed to investigate the hypothesis that there is no ...
What is the current status of trial NCT04533061?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT04533061?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT04533061?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.